Home-based Computerized Cognitive Rehabilitation in Chronic Stage Stroke (CHRONIC)

May 17, 2019 updated by: Josep M. Tormos Muñoz
This study evaluates the effectiveness of Guttmann NeuroPersonalTrainer (GNPT), a tele-rehabilitation platform developed as a tool for the cognitive rehabilitation of chronic stroke patients. All patients will receive this treatment but in different order: half will receive GNPT and the other half will receive sham cognitive training; after a washout period of three months, crossover will occur and participants from the GNPT condition will receive sham cognitive training, while participants originally from the control intervention will receive GNPT.

Study Overview

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08916
        • Institut Guttmann

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • to be over 18 years old,
  • to have been diagnosed with stroke
  • an occurrence of the injury of 12 month period ore more (chronic stage)
  • cognitive impairment confirmed by pre-intervention neuropsychological assessment

Exclusion Criteria:

  • diagnosis of language deficits or aphasia
  • motor impairment concerning upper limbs that may incapacitate them for the use of the computer
  • severe alteration of the visual field or perceptual problems
  • health status that may require further intervention or admission to a medical center during the study;
  • neurological or psychiatric history
  • substance abuse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Guttmann, NeuroPersonalTrainer
Guttmann NeuroPersonalTrainer (GNPT) 5 days per week over 6 weeks.
Guttmann NeuroPersonalTrainer (GNPT) is a telerehabilitation platform. GNPT consists of a set of computerized cognitive exercises covering different cognitive functions and subfunctions. Every task has been specifically based on cognitive paradigms to address specific cognitive subfunction. The rehabilitation process starts by assigning a patient to a therapist responsible for the treatment. The therapist has then to perform the initial neuropsychological assessment, consisting of a set of validated tests used to attention, memory and executive functions prior to the treatment. The results of these tests will be stored in GNPT system. Then, the cognitive profile is calculated using these results, and taking into account the patient's age and study level. Using this profile, the program assigns a set of computerized tasks to a certain day, configuring the input parameters of each task in order to personalize treatments.
Sham Comparator: Ictus.online
Itus.online 5 days per week over 6 weeks
An online domain which provides a daily session of one hour of duration. Each session consists of four ten-minute videos. After each video, the participant must complete a three-question quiz about the contents of the video (for example, "What animal appears in in the video?"). The difficulty level is minimal, and does not vary depending on the execution of the participant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conners Continuous Performance Test (CPT-II)
Time Frame: 1 day
To improve performance in sustained attention after receiving experimental intervention.
1 day
Rey Auditory Verbal Learning Test (RAVLT)
Time Frame: 1 day
To improve performance in short-term, long-term and recognition. This test has puntuation range from 0 to 75.
1 day
Spanish phonemic fluency test- PMR
Time Frame: 1 day
To improve performance in phonemic fluency after receiving experimental intervention.
1 day
Digit Span forward Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
To improve performance in span of immediate verbal recall after receiving experimental intervention. This subtest has a puntuation range from 2 to 9, where higher values are considered to be a better outcome.
1 day
Digit Span backward Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
To improve performance in working memory after receiving experimental intervention. This subtest has a puntuation range from 2 to 8, where higher values are considered to be a better outcome.
1 day
Letter-Number Sequencing Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
To improve performance in working memory after receiving experimental intervention. This subtest has a puntation range from 1 to 21, where higher values are considered to be a better outcome.
1 day
Rating Scale for Attentional Behavior (RSAB)
Time Frame: 1 week
RSAB comprises 14 items aimed to identify attentional difficulties on daily routines
1 week
Prospective and Retrospective Memory Questionnaire (PRMQ)
Time Frame: 1 week
PRMQ includes 16 items designed to evaluate prospective and retrospective memory in short- and long-term
1 week
Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)
Time Frame: 1 week
BRIEF-A includes 75 items designed to assess executive function behaviors on day-to-day activities.
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Digit Symbol-Coding Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
To improve performance in speed of processing. This subtest has a puntuation range from 1 to 133, where higher values are considered to be a better outcome.
1 day
Block Design Subtest from the Wechsler Adult Intelligence Scale (WAIS-III)
Time Frame: 1 day
To improve performance in visuoconstruction and planning. This subtest has a puntuation range from 1 to 68, where higher values are considered to be a better outcome.
1 day
Stroop Color and Word test (Stroop Test)
Time Frame: 1 day
To improve performance in inhibitory control
1 day
Trail Making Test A (TMT-A)
Time Frame: 1 day
To improve performance in visual attention
1 day
Trail Making Test B (TMT-B)
Time Frame: 1 day
To improve performance in task-switching
1 day
Wisconsin Card Sorting Test (WCST)
Time Frame: 1day
To improve performance in cognitive flexibility
1day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 17, 2017

Primary Completion (Actual)

February 4, 2019

Study Completion (Actual)

May 7, 2019

Study Registration Dates

First Submitted

October 26, 2017

First Submitted That Met QC Criteria

October 26, 2017

First Posted (Actual)

October 31, 2017

Study Record Updates

Last Update Posted (Actual)

May 21, 2019

Last Update Submitted That Met QC Criteria

May 17, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Guttmann, NeuroPersonalTrainer

3
Subscribe